Evaluation of pax6 mutant rat as a model for autism

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Umeda, Toshiko ^a   Takashima, Noriko ^b,c   Nakagawa, Ryoko ^b   Maekawa, Motoko ^b   Ikegami, Shiro ^c,d   Yoshikawa, Takeo ^b   Kobayashi, Kazuto ^e   Okanoya, Kazuo ^b   Inokuchi, Kaoru ^c,f   Osumi, Noriko ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c Mitsubishi Kagaku Institute of Life Sciences   (Japan)

^d SAITAMA INSTITUTE OF TECHNOLOGY   (Japan)

^e FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^f UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; TRANSCRIPTION FACTOR PAX6; EYE PROTEIN; HOMEODOMAIN PROTEIN; PAIRED BOX TRANSCRIPTION FACTOR; REPRESSOR PROTEIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; MALE; NONHUMAN; NONSENSE MUTATION; PHARMACOLOGICAL PROCEDURES; PROTEIN FUNCTION; RAT; RAT STRAIN; SEX DIFFERENCE; SOCIAL INTERACTION; VOCALIZATION; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; DISEASE MODEL; FEAR; GENETICS; MEMORY; MOUSE; MUTATION; PHENOTYPE; STEM CELL; TRANSGENIC ANIMAL; ULTRASOUND;

RATTUS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; AUTISTIC DISORDER; DISEASE MODELS, ANIMAL; EYE PROTEINS; FEAR; FEMALE; HOMEODOMAIN PROTEINS; MALE; MEMORY; MICE; MODELS, GENETIC; MUTATION; PAIRED BOX TRANSCRIPTION FACTORS; PHENOTYPE; RATS; REPRESSOR PROTEINS; STEM CELLS; ULTRASONICS; VOCALIZATION, ANIMAL;

EID: 78650974628     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015500     Document Type: Article

References (79)

1. Levy SE, Mandell DS, Schultz RT (2009) Autism. Lancet 374: 1627-1638.
2. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, et al. (1989) A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry 30: 405-416.
3. Geschwind DH (2009) Advances in autism. Annu Rev Med 60: 367-380.
4. Association AP (2000) Diagnostic and Statistical Manual of Mental Disorders. edn 4.
5. Ospina MB, Krebs Seida J, Clark B, Karkhaneh M, Hartling L, et al. (2008) Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review. PLoS One 3: e3755.
6. Hughes JR (2009) Update on autism: a review of 1300 reports published in 2008. Epilepsy Behav 16: 569-589.
7. Senju A, Johnson MH (2009) Atypical eye contact in autism: models, mechanisms and development. Neurosci Biobehav Rev 33: 1204-1214.
8. Ronald A, Happe F, Bolton P, Butcher LM, Price TS, et al. (2006) Genetic heterogeneity between the three components of the autism spectrum: a twin study. J Am Acad Child Adolesc Psychiatry 45: 691-699.
9. Dworzynski K, Happe F, Bolton P, Ronald A (2009) Relationship between symptom domains in autism spectrum disorders: a population based twin study. J Autism Dev Disord 39: 1197-1210.
10. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, et al. (1995) Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 25: 63-77.
11. Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R (2010) Genetics of autistic disorders: review and clinical implications. Eur Child Adolesc Psychiatry 19: 169-178.
12. Becker KG (2004) The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 62: 309-317.
13. Bill BR, Geschwind DH (2009) Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev 19: 271-278.
14. Walther C, Gruss P (1991) Pax-6, a murine paired box gene, is expressed in the developing CNS. Development 113: 1435-1449.
15. Stoykova A, Gruss P (1994) Roles of Pax-genes in developing and adult brain as suggested by expression patterns. J Neurosci 14: 1395-1412.
16. Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, et al. (2002) Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110: 429-441.
17. Sakurai K, Osumi N (2008) The neurogenesis-controlling factor, Pax6, inhibits proliferation and promotes maturation in murine astrocytes. J Neurosci 28: 4604-4612.
18. Ton CC, Hirvonen H, Miwa H, Weil MM, Monaghan P, et al. (1991) Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region. Cell 67: 1059-1074.
19. Hanson I, Van Heyningen V (1995) Pax6: more than meets the eye. Trends Genet 11: 268-272.
20. Fischbach BV, Trout KL, Lewis J, Luis CA, Sika M (2005) WAGR syndrome: a clinical review of 54 cases. Pediatrics 116: 984-988.
21. Xu S, Han JC, Morales A, Menzie CM, Williams K, et al. (2008) Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet Genome Res 122: 181-187.
22. Malandrini A, Mari F, Palmeri S, Gambelli S, Berti G, et al. (2001) PAX6 mutation in a family with aniridia, congenital ptosis, and mental retardation. Clin Genet 60: 151-154.
23. Davis LK, Meyer KJ, Rudd DS, Librant AL, Epping EA, et al. (2008) Pax6 39 deletion results in aniridia, autism and mental retardation. Hum Genet 123: 371-378.
24. Graziano C, D'Elia AV, Mazzanti L, Moscano F, Guidelli Guidi S, et al. (2007) A de novo nonsense mutation of PAX6 gene in a patient with aniridia, ataxia, and mental retardation. Am J Med Genet A 143A: 1802-1805.
25. Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, et al. (2007) Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39: 319-328.
26. Maekawa M, Iwayama Y, Nakamura K, Sato M, Toyota T, et al. (2009) A novel missense mutation (Leu46Val) of PAX6 found in an autistic patient. Neurosci Lett 462: 267-271.
27. Osumi N, Hirota A, Ohuchi H, Nakafuku M, Iimura T, et al. (1997) Pax-6 is involved in the specification of hindbrain motor neuron subtype. Development 124: 2961-2972.
28. Matsuo T, Osumi-Yamashita N, Noji S, Ohuchi H, Koyama E, et al. (1993) A mutation in the Pax-6 gene in rat small eye is associated with impaired migration of midbrain crest cells. Nat Genet 3: 299-304.
29. Becker A, Grecksch G, Bernstein HG, Hollt V, Bogerts B (1999) Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology (Berl) 144: 333-338.
30. Ikegami S, Inokuchi K (2000) Antisense DNA against calcineurin facilitates memory in contextual fear conditioning by lowering the threshold for hippocampal long-term potentiation induction. Neuroscience 98: 637-646.
31. Bouwknecht JA, van der Gugten J, Groenink L, Olivier B, Paylor RE (2004) Effects of repeated testing in two inbred strains on flesinoxan dose-response curves in three mouse models for anxiety. Eur J Pharmacol 494: 35-44.
32. Wells CE, Krikke B, Saunders J, Whittington A, Lever C (2009) Changes to open field surfaces typically used to elicit hippocampal remapping elicit graded exploratory responses. Behav Brain Res 197: 234-238.
33. Costall B, Coughlan J, Horovitz ZP, Kelly ME, Naylor RJ, et al. (1989) The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition. Pharmacol Biochem Behav 33: 573-579.
34. Kanakubo S, Nomura T, Yamamura K, Miyazaki J, Tamai M, et al. (2006) Abnormal migration and distribution of neural crest cells in Pax6 heterozygous mutant eye, a model for human eye diseases. Genes Cells 11: 919-933.
35. Porsolt RD, Anton G, Blavet N, Jalfre M (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379-391.
36. Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106: 274-285.
37. Branchi I, Santucci D, Alleva E (2001) Ultrasonic vocalisation emitted by infant rodents: a tool for assessment of neurobehavioural development. Behav Brain Res 125: 49-56.
38. Anderson GM (2002) Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism. J Am Acad Child Adolesc Psychiatry 41: 1513-1516.
39. Anderson GM, Horne WC, Chatterjee D, Cohen DJ (1990) The hyperserotonemia of autism. Ann N Y Acad Sci 600: 331-340; discussion 341-332.
40. Huang CH, Santangelo SL (2008) Autism and serotonin transporter gene polymorphisms: a systematic review and meta-analysis. Am J Med Genet B Neuropsychiatr Genet 147B: 903-913.
41. Maekawa M, Takashima N, Matsumata M, Ikegami S, Kontani M, et al. (2009) Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PLoS One 4: e5085.
42. Brieden T, Ujeyl M, Naber D (2002) Psychopharmacological treatment of aggression in schizophrenic patients. Pharmacopsychiatry 35: 83-89.
43. Osumi N (2001) The role of Pax6 in brain patterning. Tohoku J Exp Med 193: 163-174.
44. Glaser T, Jepeal L, Edwards JG, Young SR, Favor J, et al. (1994) PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects. Nat Genet 7: 463-471.
45. Schmahl W, Knoedlseder M, Favor J, Davidson D (1993) Defects of neuronal migration and the pathogenesis of cortical malformations are associated with Small eye (Sey) in the mouse, a point mutation at the Pax-6-locus. Acta Neuropathol 86: 126-135.
46. Maekawa M, Takashima N, Arai Y, Nomura T, Inokuchi K, et al. (2005) Pax6 is required for production and maintenance of progenitor cells in postnatal hippocampal neurogenesis. Genes Cells 10: 1001-1014.
47. Haba H, Nomura T, Suto F, Osumi N (2009) Subtype-specific reduction of olfactory bulb interneurons in Pax6 heterozygous mutant mice. Neurosci Res 65: 116-121.
48. Sisodiya SM, Free SL, Williamson KA, Mitchell TN, Willis C, et al. (2001) PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat Genet 28: 214-216.
49. Free SL, Mitchell TN, Williamson KA, Churchill AJ, Shorvon SD, et al. (2003) Quantitative MR image analysis in subjects with defects in the PAX6 gene. Neuroimage 20: 2281-2290.
50. Mitchell TN, Free SL, Williamson KA, Stevens JM, Churchill AJ, et al. (2003) Polymicrogyria and absence of pineal gland due to PAX6 mutation. Ann Neurol 53: 658-663.
51. Hardan AY, Pabalan M, Gupta N, Bansal R, Melhem NM, et al. (2009) Corpus callosum volume in children with autism. Psychiatry Res 174: 57-61.
52. Nishina S, Kohsaka S, Yamaguchi Y, Handa H, Kawakami A, et al. (1999) PAX6 expression in the developing human eye. Br J Ophthalmol 83: 723-727.
53. Tuoc TC, Radyushkin K, Tonchev AB, Pinon MC, Ashery-Padan R, et al. (2009) Selective cortical layering abnormalities and behavioral deficits in cortexspecific Pax6 knock-out mice. J Neurosci 29: 8335-8349.
54. Guo H, Hong S, Jin XL, Chen RS, Avasthi PP, et al. (2000) Specificity and efficiency of Cre-mediated recombination in Emx1-Cre knock-in mice. Biochem Biophys Res Commun 273: 661-665.
55. Perry W, Minassian A, Lopez B, Maron L, Lincoln A (2007) Sensorimotor gating deficits in adults with autism. Biol Psychiatry 61: 482-486.
56. McAlonan GM, Daly E, Kumari V, Critchley HD, van Amelsvoort T, et al. (2002) Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain 125: 1594-1606.
57. Klin A, Saulnier CA, Sparrow SS, Cicchetti DV, Volkmar FR, et al. (2007) Social and communication abilities and disabilities in higher functioning individuals with autism spectrum disorders: the Vineland and the ADOS. J Autism Dev Disord 37: 748-759.
58. Frith U (1993) Autism. Sci Am 268: 108-114.
59. Jamain S, Radyushkin K, Hammerschmidt K, Granon S, Boretius S, et al. (2008) Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A 105: 1710-1715.
60. Shu W, Cho JY, Jiang Y, Zhang M, Weisz D, et al. (2005) Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. Proc Natl Acad Sci U S A 102: 9643-9648.
61. Young DM, Schenk AK, Yang SB, Jan YN, Jan LY (2010) Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism. Proc Natl Acad Sci U S A 107: 11074-11079.
62. Wing L (1981) Sex ratios in early childhood autism and related conditions. Psychiatry Res 5: 129-137.
63. Hartley SL, Sikora DM (2009) Sex Differences in Autism Spectrum Disorder: An Examination of Developmental Functioning, Autistic Symptoms, and Coexisting Behavior Problems in Toddlers. J Autism Dev Disord.
64. McEuen JG, Semsar KA, Lim MA, Bale TL (2009) Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity. Endocrinology 150: 3709-3716.
65. Shors TJ, Chua C, Falduto J (2001) Sex differences and opposite effects of stress on dendritic spine density in the male versus female hippocampus. J Neurosci 21: 6292-6297.
66. Wellmann K, Lewis B, Barron S (2010) Agmatine reduces ultrasonic vocalization deficits in female rat pups exposed neonatally to ethanol. Neurotoxicol Teratol 32: 158-163.
67. Cook EH, Leventhal BL (1996) The serotonin system in autism. Curr Opin Pediatr 8: 348-354.
68. Spivak B, Golubchik P, Mozes T, Vered Y, Nechmad A, et al. (2004) Low platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsychobiology 50: 157-160.
69. Rigdon GC, Weatherspoon JK (1992) 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263: 486-493.
70. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234-258.
71. Van Steenwinckel J, Noghero A, Thibault K, Brisorgueil MJ, Fischer J, et al. (2009) The 5-HT2A receptor is mainly expressed in nociceptive sensory neurons in rat lumbar dorsal root ganglia. Neuroscience 161: 838-846.
72. Brauer D, Strobel A, Hensch T, Diers K, Lesch KP, et al. (2009) Genetic variation of serotonin receptor function affects prepulse inhibition of the startle. J Neural Transm 116: 607-613.
73. Arranz M, Collier D, Sodhi M, Ball D, Roberts G, et al. (1995) Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 346: 281-282.
74. Burnet PW, Chen CP, McGowan S, Franklin M, Harrison PJ (1996) The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience 73: 531-540.
75. Shinohara T, Tomizuka K, Miyabara S, Takehara S, Kazuki Y, et al. (2001) Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. Hum Mol Genet 10: 1163-1175.
76. Danaceau JP, Anderson GM, McMahon WM, Crouch DJ (2003) A liquid chromatographic-tandem mass spectrometric method for the analysis of serotonin and related indoles in human whole blood. J Anal Toxicol 27: 440-444.
77. Sano H, Yasoshima Y, Matsushita N, Kaneko T, Kohno K, et al. (2003) Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function. J Neurosci 23: 9078-9088.
78. Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, et al. (2000) Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists. J Neurosci 20: 4325-4336.
79. Kew JN, Koester A, Moreau JL, Jenck F, Ouagazzal AM, et al. (2000) Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site. J Neurosci 20: 4037-4049.